ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Health Technology

Hanmi Pharmaceutical Co., Ltd.

Business Summary

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong, South Korea.

Financial Highlights

Dec 2019 KRWUSD
Revenue1,113.64B954.95M
Gross Profit643,749.84M552.01M
Operating income103,877.84M89.07M
Income before tax83,269.64M71.40M
Net income52,109.66M44.68M
EBITDA159,290.01M136.59M
Diluted EPS4,514.463.87
Dividends Per Share490.190.42
Total Assets1,913.70B1,654.81M
Total liabilities1,091.44B943.78M
Total equity723,795.03M625.87M
Operating cash flow12,446.62M10.67M
Currency in KRWCurrency in USD

Historical Data

 Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019
Revenue 1,317.53B 882,724.83M 916,586.23M 1,015.96B 1,113.64B
Gross Profit 885,237.19M 442,522.46M 511,632.88M 552,497.93M 643,749.84M
Operating income 211,799.97M 26,771.86M 82,163.67M 83,646.47M 103,877.84M
Income before tax 209,584.51M 7,997.73M 58,849.50M 50,354.80M 83,269.64M
Net income 154,443.35M 23,325.62M 60,434.21M 24,891.11M 52,109.66M
EBITDA 261,931.07M 65,546.52M 119,135.28M 130,767.17M 159,290.01M
Diluted EPS 13,060.41 1,974.47 5,269.12 2,115.32 4,514.46
Dividends Per Share 1,726.81 0 471.16 480.58 490.19
Total Assets 1,722.59B 1,596.97B 1,660.93B 1,691.20B 1,913.70B
Total liabilities 977,784.81M 862,453.63M 868,509.82M 901,953.19M 1,091.44B
Total equity 674,945.18M 659,461.20M 711,710.95M 703,228.12M 723,795.03M
Operating cash flow 104,126.01M 419,187.50M -62,905.20M 25,982.25M 12,446.62M
 Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019
Revenue 1,164.10M 760.84M 810.77M 923.16M 954.95M
Gross Profit 782.14M 381.42M 452.56M 502.03M 552.01M
Operating income 187.13M 23.07M 72.67M 76.00M 89.07M
Income before tax 185.17M 6.89M 52.05M 45.75M 71.40M
Net income 136.45M 20.10M 53.45M 22.61M 44.68M
EBITDA 231.42M 56.49M 105.38M 118.82M 136.59M
Diluted EPS 11.53 1.70 4.66 1.92 3.87
Dividends Per Share 1.52 0 0.41 0.43 0.42
Total Assets 1,469.09M 1,322.21M 1,551.47M 1,515.69M 1,654.81M
Total liabilities 833.89M 714.06M 811.27M 808.34M 943.78M
Total equity 575.62M 546.00M 664.80M 630.24M 625.87M
Operating cash flow 92.00M 361.30M -55.64M 23.60M 10.67M

Valuation Measures

Dec 2019
PER65.67
ROA2.89%
ROE7.30%
Operating margin9.32%
Profit margin4.67%

Key executives

  • Co-President, Co-CEO & Director: Sae-Chang Kwon
  • Co-President, Co-CEO & Director: Jong-Soo Woo
  • Co-President, Director & Head-Business Development: Jong-Yoon Lim
  • Senior Managing Director & Head-Research Center: Gwi-Hyun Seo
  • Vice President: Jong-Hoon Lim

Shareholders

  • Hanmi Science Co., Ltd. (41.3%)
  • National Pension Service of Korea (9.0%)
  • SHIN DONG-GUK (7.5%)
  • The Vanguard Group, Inc. (1.8%)
  • BlackRock Fund Advisors (1.3%)
  • Samsung Asset Management Co., Ltd. (0.9%)
  • Norges Bank Investment Management (0.8%)
  • Hanmi Pharmaceutical Co., Ltd. (0.6%)
  • Mirae Asset Global Investments Co., Ltd. (0.5%)
  • TOBAM SAS (0.3%)

Contact Details

Related Companies

  • Hanmi Pharmaceutical Co. Ltd. Esop
  • Hanmi Fine Chemical Co., Ltd.

Competitors

  • Daiichi Sankyo Company, Limited
  • Astellas Pharma Inc.
  • Sanofi
  • AstraZeneca PLC
  • Takeda Pharmaceutical Co. Ltd.
  • Amgen Inc.
  • Eli Lilly and Company
  • Merck KGaA
  • Novo Nordisk A/S Class B
  • Apellis Pharmaceuticals, Inc.
  • Reyon Pharmaceutical Co., Ltd.
  • Boryung Pharmaceutical Co., Ltd.
  • Chong Kun Dang Pharmaceutical Corp.
  • Kwang Dong Pharmaceutical Co., Ltd.
  • Dong-A ST Co., Ltd.
  • Kyongbo Pharmaceutical Co., Ltd.
  • BCWORLD PHARM. Co., Ltd.
  • Hana Pharm Co., Ltd.
  • Jeil Pharmaceutical Co. Ltd.
  • Wooridul Pharmaceutical Ltd.
  • Celltrion Pharm Inc.
  • IL DONG PHARMACEUTICAL CO., LTD.
  • JEIL PHARMA HOLDINGS INC.
  • Shinpoong Pharmaceutical Co., Ltd.
  • Sam-A Pharm. Co., Ltd.
  • Kukje Pharma Co. Ltd.
  • Whan In Pharmaceutical Co., Ltd.
  • Daewoong Pharmaceutical Co., Ltd.
  • Yuhan Corporation
  • JW Pharmaceutical Corporation
Last Updated on 4 Jun, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media